WebApr 30, 2007 · Swiss claims effectively protect a new use of a known pharmaceutical ingredient. However, the interpretation of relevant case law by IPONZ has been rather restrictive and is reflected in its Guidelines for the Examination of Swiss-type Claims that were issued in September 2006. Swiss-type claims are used to effectively protect the use of an active substance or composition in the manufacture of a medicament for the treatment of a “new use”, where the substance or composition had previously been used for the treatment of a different condition i.e. a different use. See more The practice note of 2008 entitled Contrary to morality Raising objections under section 17(1) has caused some confusion with respect to the nature of what … See more
G‑VI, 7.1 First or further medical use of known products - EPO
WebWith regard to the inhomogeneous requirements on the allowed forms for medical use claims on a national level, Swiss-type claims often have been included in parallel to ensure the maximum scope of protection. It is worth noting that Swiss-type claims have not been considered admissible in all contracting states of the European Patent Convention. WebAug 2, 2024 · IPONZ has also found that the novelty of Swiss-style claims can reside in new dosage forms, modes of administration, treatment regimens or patient groups. 3 Swiss … the voice 2022 top 5 finalists
Patents hearing decisions - Intellectual Property Office of New …
WebNov 24, 2006 · Facts. AU 721477 in the name of Prosidion Limited (“Prosidion”) proceeded to acceptance (allowance) with claims in the form of: The use of compound X for the preparation of a medicament for the treatment of condition Y. This type of claim is commonly referred to as a “Swiss-style” claim. After acceptance, Prosidion sought to … WebThis guideline outlines IPONZ practice for requests to amend the complete specification of a patent before acceptance under s 40, which reads: 40 Amendment of complete … WebFeb 24, 2024 · Unlike Europe-style claims, the limitation "for treating Disease Y" reads into the "Swiss-type" second medical use claim, therefore providing back up if a prior art, as mentioned above, arises. Further, Swiss-style claims need to recite specific diseases to be treated in order to avoid a lack of clarity objection. the voice 2022 tf1 replay